Cleared Special

Neuro.Al Algorithm (K200750) - FDA 510(k) Clearance

Class II Radiology device cleared through the Special 510(k) pathway - typically does not require clinical trials.

K200750 · Terarecon,Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2020
Decision
228d
Days
Class 2
Risk

K200750 is an FDA 510(k) clearance for the Neuro.Al Algorithm. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Terarecon,Inc. (Durham, US). The FDA issued a Cleared decision on November 6, 2020 after a review of 228 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Terarecon,Inc. devices

Submission Details

510(k) Number K200750 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 23, 2020
Decision Date November 06, 2020
Days to Decision 228 days
Submission Type Special
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
121d slower than avg
Panel avg: 107d · This submission: 228d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 799
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K200750.
DTX Studio Clinic
K203156 · Nobel Biocare AB · Nov 2020
DBSWIN, VISTAEASY
K203287 · D?rr Dental SE · Nov 2020
PROView
K193306 · GE Medical Systems SCS · Nov 2020
MyHip Planner & Verifier
K200350 · Medacta International S.A. · Nov 2020
CloudVue
K203058 · International Medical Solutions, Inc. · Oct 2020
OrthoNext Platform System
K202519 · Orthofix Srl · Oct 2020